Time course of surface electromyography during walking of children with spastic cerebral palsy treated with botulinum toxin type A and its rehabilitation implications

Clin Biomech (Bristol, Avon). 2024 Jan:111:106147. doi: 10.1016/j.clinbiomech.2023.106147. Epub 2023 Nov 15.

Abstract

Background: The timing of the effects of botulinum toxin A on spastic muscles is not yet fully clarified. The goal of this study was to follow the temporal changes of surface electromyographic activity of lower limb muscles during walking, after a therapeutic dose of botulinum toxin A injected into the calf muscles of children with spastic cerebral palsy.

Methods: A group of children with spastic equinus foot was administered botulinum toxin A into the gastrocnemius medialis and lateralis muscles. Surface electromyographic activity of the tibialis anterior, gastrocnemius medialis, rectus femoris and medial hamstrings, was recorded before botulinum toxin A injections and after 4, 8, and 16 weeks. Children walked on ground and on a treadmill at an incline of 0% and 12%. The area of electromyographic activity and the index of muscle co-contraction were calculated for specific segments of gait cycle.

Findings: Botulinum toxin A did not modify the speed of gait on ground. ANOVA showed significant differences in electromyography during the stance phase segments with a maximum decrease between 4 and 8 weeks' post botulinum toxin A and a full recovery at 16 weeks. A significant co-contraction of rectus femoris/gastrocnemius medialis, between 0 and 20% and 35-50% of the gait cycle, was observed from the 4th to the 8th week post- botulinum toxin A for both treadmill settings.

Interpretation: The temporal identification of deterioration/recovery of electromyographic activity as well as of muscle co-contractions, could be key elements in a rehabilitation program planning combined with botulinum toxin A.

Keywords: Botulinum toxin type A; Cerebral palsy; Co-contraction; Gait spatiotemporal parameters; Surface electromyography; Time course.

MeSH terms

  • Botulinum Toxins, Type A* / therapeutic use
  • Cerebral Palsy* / drug therapy
  • Child
  • Electromyography
  • Gait / physiology
  • Humans
  • Muscle Spasticity / drug therapy
  • Muscle, Skeletal
  • Walking

Substances

  • Botulinum Toxins, Type A